T. A. Waldmann - Concepedia

Author

T. A. Waldmann

Also Known As

T A Waldmann, T Waldmann, T. A. WALDMANN, T. A. Waldmann, T. Waldmann, T.A. Waldmann, Thomas A Waldmann, Thomas A. Waldmann

Publications

Citations

H-Index

104

Concepts

All Affiliations

National Cancer Institute National Institutes of Health

About

T. A. Waldmann is an author at National Cancer Institute specializing in medicine, immunology, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	31	5K
2	Allergy	13	13	2.1K
3	Health Sciences	2	2	119
4	Natural Sciences	2	2	196
5	Public Health	1	1	117

T. A. Waldmann

Publications

5.7K

Citations

H-Index

Page 1

	Year	Citations
The Sézary syndrome: a malignant proliferation of helper T cells. S Broder, Richard L. Edelson, Marvin A. Lutzner, Journal of Clinical Investigation Sézary SyndromeHematological MalignancyLymphoid NeoplasiaAllergyAutoimmune Disease	1976	481
Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex. Mitsuru Tsudo, Robert W. Kozak, C K Goldman, Proceedings of the National Academy of Sciences ImmunologyImmunologic MechanismAntigen ProcessingNon-tac PeptideImmune System	1986	465
Contrasting Roles of IL-2 and IL-15 in the Life and Death of Lymphocytes Implications for Immunotherapy T. A. Waldmann Immunity InflammationAllergyAutoimmune DiseaseMedicineImmune Regulation	2001	435
Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells Maria Cristina Mingari, Franca Gerosa, Giovanna Carrà, Nature InflammationActivated B CellsActivated T CellsCytokineAutoimmune Disease	1984	382
Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia. S J Korsmeyer, Warner C. Greene, Jeffrey Cossman, Proceedings of the National Academy of Sciences Lymphocyte DevelopmentImmunologyPathologyAntigen ProcessingHairy Cell Leukemia	1983	374
A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. II. Expression of Tac antigen on activated cytotoxic killer T cells, suppressor cells, and on one of two types of helper T cells. T. Uchiyama, David L. Nelson, T.A. Fleisher, The Journal of Immunology	1981	347
Interleukin (IL) 15/IL-T production by the adult T-cell leukemia cell line HuT-102 is associated with a human T-cell lymphotrophic virus type I region /IL-15 fusion message that lacks many upstream AUGs that normally attenuates IL-15 mRNA translation. Richard N. Bamford, A P Battiata, J. D. Burton, Proceedings of the National Academy of Sciences T-regulatory CellImmunologyPathologyImmunologic MechanismIl-15 Synthesis	1996	234
Loss of suppressor T cells in adult NZB/NZW mice. Randall S. Krakauer, T. A. Waldmann, Warren Strober The Journal of Experimental Medicine Knockout MouseAdult Nzb/nzw MiceImmune Cell DevelopmentPwm-driven Igm BiosynthesisImmunology	1976	227
Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factor. T. A. Waldmann, Warner C. Greene, Prem S. Sarin, Journal of Clinical Investigation Human ReceptorTcgf-tcgf Receptor SystemT-regulatory CellImmunologyPathology	1984	225
T-lymphocyte interleukin 2-dependent tyrosine protein kinase signal transduction involves the activation of p56lck. Ivan D. Horak, Ronald E. Gress, Philip J. Lucas, Proceedings of the National Academy of Sciences T-regulatory CellImmunologyImmune RegulationImmunologic MechanismIl-2 Treatment	1991	212

Page 1